[Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer].
Schulman
Sam
S
Centrum för hematologi, Karolinska Universitetssjukhuset Solna. sam.schulman@ks.se
D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D013997:Time Factors; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight